Design, synthesis and functional characteristics of low molecular weight proline-rich motif (PRM) mimetics recognized by PRM binding domains
Design, synthesis and functional characteristics of low molecular weight proline-rich motif (PRM) mimetics recognized by PRM binding domains
批准号:
35756057
负责人:
Dr. Michael Beyermann
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Units
财政年份:
2007
资助国家:
德国
项目状态:
已结题
起止时间:
2006-12-31 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A major reason for the difficulty in modulating protein-protein interactions (PPI) by small molecules is that they typically possess flat and rather large binding interfaces, displaying little concavity. These interactions are classified according to their specificity. An important dass of such protein domains exhibits solvent exposed regions that are able to bind the proline-rich motifs (PRM) of their target proteins. Currently, six distinct families of PRM-binding domains (PRO) (Src-homology 3 (SH3) domains, WW domains, EVH1 (Ena/VASP homology 1) domains, GYF domains, UEV (ubiquitin E2 variant) domains and profilin are known. Present in many multi-component signaling complexes, such PRDs recognize characteristic patterns of proline residues by means of stacked aromatic amino acids on their surface. Additionally, the specificity of this interaction is influenced by flanking binding epitopes. The aim of this project is to discover new specific modulators of the human EVH1 domain, the SH3-domain of the src kinase Fyn, and the YAP-WW domain, based on a new polyproline II helix mimetic structure and structural modifications developed and characterized during the previous project phase. These compounds represent a new dass of PRM mimetics and may serve äs starting points for the development of specific, pharmacologically relevant inhibitors of PRM- mediated protein-protein interaction (PPI). Additionally, we search for new lead compounds to modulate the three families of domain by screening the ChemBioNet library and by virtual screening of specifically assembled focused libraries. The project combines rational, structurebased small molecule design, structural biology, stereoselective synthesis of novel scaffolds, peptide synthesis, new scaffold-based ligation strategies, compound screening and functional characterization of the PRO modulators.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1055/s-0030-1258428
发表时间:
2011-03-01
期刊:
SYNTHESIS-STUTTGART
影响因子:
2.6
作者:
[Huy, Peter, Schmalz, Hans-Guenther]
通讯作者:
Schmalz, Hans-Guenther
Stereoselective Synthesis of Proline‐Derived Dipeptide Scaffolds (ProM‐3 and ProM‐7) Rigidified in a PPII Helix Conformation
立体选择性合成以 PPII 螺旋构象刚性化的脯氨酸衍生二肽支架(ProMâ3 和 ProMâ7)
DOI:
10.1002/ejoc.201301875
发表时间:
2014
期刊:
European Journal of Organic Chemistry
影响因子:
2.8
作者:
[Reuter, Kleczka, de Mazancourt, Neudörfl, Kühne, Schmalz]
通讯作者:
Schmalz
Synthese, Reinigung und Charakterisierung `schwieriger` Peptide über ihre Depsipeptidanaloga
-
批准号:5448773
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Dr. Michael Beyermann
-
依托单位:
Organisation und Funktion eines Transduktions-Komplexes in Sehstäbchen
-
批准号:5376661
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:Dr. Michael Beyermann
-
依托单位:
国内基金
海外基金
登录
查看更多内容
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
“肠—肝轴”PPARα/CYP8B1胆汁酸合成信号通路在减重手术改善糖脂代谢中的作用与机制
-
批准号:82370902
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:田景琰
-
依托单位:
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
-
批准号:32372856
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李隐侠
-
依托单位:
脂肪酸合成通过GDF15/IRS2介导胰岛素抵抗促进血管内皮细胞活化导致脓毒症肺损伤的机制研究
-
批准号:82372203
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李然然
-
依托单位:
环状RNA circ-PRKAA1调控肝癌细胞脂代谢重编程的研究
-
批准号:32000527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:李启东
-
依托单位:
ALDH6A1缺损重塑糖脂代谢促进肝细胞癌发生的机制研究
-
批准号:91957109
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2019
-
负责人:黄赞
-
依托单位:
新型滤波器综合技术-直接综合技术(Direct synthesis Technique)的研究及应用
-
批准号:61671111
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:肖飞
-
依托单位:
双硅化合物反应及天然产物合成应用研究
-
批准号:21172150
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:宋振雷
-
依托单位:
新型M4受体选择性拮抗剂的研究
-
批准号:30973615
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:何新华
-
依托单位:
基于penicillide结构的类天然产物合成及其胆固醇酯转运蛋白抑制的研究
-
批准号:20872019
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:雷新胜
-
依托单位: